White Paper

Biologic Drug Products: A 5-Point Strategy For Building A Robust CMC Dossier

By Daniela Decina, Sr. Director, Regulatory Affairs, Thermo Fisher Scientific, and Michele Duggan, Sr. Manager, Regulatory Affairs, Thermo Fisher Scientific

GettyImages-1303133599-lab-computer-research-virus
VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of ECM Connection? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.